REGENCELL BIOSCIENCE HLDGS L's ticker is and the CUSIP is G7487R100. A total of 6 filers reported holding REGENCELL BIOSCIENCE HLDGS L in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,564 | -30.1% | 326 | +8.3% | 0.00% | – |
| Q2 2023 | $6,532 | -15.0% | 301 | +1.3% | 0.00% | – |
| Q1 2023 | $7,686 | +0.6% | 297 | +5.7% | 0.00% | – |
| Q4 2022 | $7,643 | +9.2% | 281 | +23.8% | 0.00% | – |
| Q3 2022 | $7,000 | +40.0% | 227 | +52.3% | 0.00% | – |
| Q2 2022 | $5,000 | – | 149 | +2383.3% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 6 | -98.8% | 0.00% | – |
| Q3 2021 | $11,000 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qube Research & Technologies Ltd | 17,329 | $371,000 | 0.00% |
| UBS Group AG | 244 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 2,240 | $48,000 | 0.00% |
| MORGAN STANLEY | 6 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 432 | $10,000 | 0.00% |